September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
December 2025
The global chatbots for mental health and therapy market size is expected to be worth around USD 2.38 billion by 2034 with a CAGR of 5.7% from 2025 to 2035.
September 2026
The cancer immunotherapy market size is calculated at USD 151.26 billion in 2026 and is projected to hit around USD 367.63 billion by 2035, at a CAGR of 10.42%.
September 2026
The global circadian rhythm sleep disorders market size was evaluated at USD 2.90 billion in 2026 and is predicted to hit around USD 5.25 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 9.39 billion in 2026, with a CAGR of 9.12%.
September 2026
The global cognitive behavioral therapy market size is expected to attain around USD 34.04 billion by 2034 from USD 10.48 billion in 2026 with a CAGR of 15.96%.
September 2026
The global personalized cell therapy market size was evaluated at USD 46.06 billion in 2026 and is predicted to reach around USD 235.65 billion by 2034, with a CAGR of 22.81%.
September 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 4.08 billion in 2026, with a CAGR of 27.55%.
September 2026
The global radiotherapy monitoring devices market size is estimated to hit around USD 2.48 billion by 2035 increasing from USD 1.29 billion in 2025, with a CAGR of 6.74%.
September 2026
The global advanced therapy medicinal products market size is projected to hit around USD 192.67 billion by 2035 increasing from USD 49.11 billion in 2026, with a CAGR of 16.44%.
September 2026
The global radiation therapy market size was estimated at USD 8.64 billion in 2026 and is expected to hit around USD 19.29 billion by 2035 with a CAGR of 9%.
September 2026
The global proton therapy market size surpassed USD 734.91 million in 2026 and is projected to surpass around USD 2,229.88 million by 2035 with a CAGR of 13.14%.
September 2026
The continuous renal replacement therapy market size was USD 1.71 billion in 2026, with leading continuous renal replacement therapy market players including baxter international inc, nikkiso co. ltd, infomed sa, Medtronic plc, bellco.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.83 billion in 2026, with a CAGR of 9.70%.
September 2026
The global physical therapy market size is estimated to hit around USD 52.53 billion by 2035, increasing from USD 27.95 billion in 2026, with a CAGR of 7.27%.
September 2026
The global oxygen therapy equipment market size was evaluated at USD 5.61 billion in 2026 and is predicted to hit around USD 11.92 billion by 2035, growing at a CAGR of 8.74%.
September 2026
The global compounding chemotherapy market size was evaluated at USD 7.39 billion in 2026 and is predicted to surge around USD 13.36 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The global intensity modulated radiotherapy market size is estimated to hit around USD 5.10 billion by 2035 increasing from USD 2.89 billion in 2026, with a CAGR of 6.52 %.
September 2026
The global particle therapy market size is expected to increase from USD 2.00 billion in 2026 to hit around USD 3.92 billion by 2035, growing at a CAGR of 7.75%.
September 2026
The global image guided radiation therapy market size was evaluated at USD 2.23 billion in 2026 and is predicted to hit around USD 3.83 billion by 2035, growing at a CAGR of 6.20%.
September 2026
The U.S. brachytherapy market was worth USD 370.79 million in 2026, with key U.S. brachytherapy market players including Becton Dickinson & Co, Eckert & Ziegler Bebig SA, Elekta AB ADR.
September 2026
The global radioimmunotherapy market size was evaluated at USD 3.65 billion in 2026 and is expected to attain around USD 14.36 billion by 2035, with a CAGR of 16.46%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The global in vivo CAR-T therapy market size was evaluated at USD 861.25 million in 2026 and is predicted to hit around USD 10,841.07 million by 2035, growing at a CAGR of 32.50%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com